Correlating skin toxicity and steroid treatment with outcomes of anti-PD-1 therapy for patients with metastatic melanoma

被引：0

作者：

Quach, Henry T. ^{[1
]}

Johnson, Douglas B. ^{[2
]}

Dewan, Anna K. ^{[3
]}

机构：

[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA

[3] Vanderbilt Univ, Med Ctr, Dept Dermatol, Nashville, TN USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

10388

引用

页码：AB39 / AB39

页数：1

共 50 条

[31] Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma
Patrinely, James R., Jr.
Baker, Laura X.
Davis, Elizabeth J.
Song, Haocan
Ye, Fei
Johnson, Douglas B.
CANCER, 2020, 126 (15) : 3448 - 3455
[32] Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma
Reddy, Swathi B.
Possick, Jennifer D.
Kluger, Harriet M.
Galan, Anjela
Han, Dale
JOURNAL OF IMMUNOTHERAPY, 2017, 40 (08) : 307 - 311
[33] Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma
Kubo, Yosuke
Fukushima, Satoshi
Inamori, Yukiko
Tsuruta, Mina
Egashira, Sho
Yamada-Kanazawa, Saori
Nakahara, Satoshi
Tokuzumi, Aki
Miyashita, Azusa
Aoi, Jun
Kajihara, Ikko
Tomita, Yusuke
Wakamatsu, Kazumasa
Jinnin, Masatoshi
Ihn, Hironobu
JOURNAL OF DERMATOLOGICAL SCIENCE, 2019, 93 (01) : 33 - 40
[34] Prognostic utility of the CALLY index in metastatic melanoma: building a nomogram for Patients on Anti-PD-1 therapy
Acar, Caner
Yuksel, Haydar cagatay
Sahin, Gokhan
Acar, Fatma Pinar
Gunenc, Damla
Karaca, Burcak
CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
[35] Safety and efficacy of anti-PD-1 antibodies in elderly patients with metastatic melanoma
Rai, R.
McQuade, J. L.
Wang, D. Y.
Park, J. J.
Nahar, K.
Sosman, J. A.
Beckermann, K. E.
Haydu, L. E.
Lo, S.
Rubinstein, S.
Beckermann, K. E.
McKean, M.
Matthew, S.
Guminski, A.
Carlino, M. S.
Davies, M.
Johnson, D. B.
Long, G. V.
Menzies, A. M.
ANNALS OF ONCOLOGY, 2016, 27
[36] The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, Vyara
Fessler, Jessica
Bao, Riyue
Chongsuwat, Tara
Zha, Yuanyuan
Alegre, Maria-Luisa
Luke, Jason J.
Gajewski, Thomas F.
SCIENCE, 2018, 359 (6371) : 104 - +
[37] Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, Vyara
Fessler, Jessica
Bao, Riyue
Chongsuwat, Tara
Zha, Yuanyuan
Alegre, Maria-Luisa
Luke, Jason
Gajewski, Thomas
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[38] Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Menzies, A. M.
Johnson, D. B.
Ramanujam, S.
Atkinson, V. G.
Wong, A. N. M.
Park, J. J.
McQuade, J. L.
Shoushtari, A. N.
Tsai, K. K.
Eroglu, Z.
Klein, O.
Hassel, J. C.
Sosman, J. A.
Guminski, A.
Sullivan, R. J.
Ribas, A.
Carlino, M. S.
Davies, M. A.
Sandhu, S. K.
Long, G. V.
ANNALS OF ONCOLOGY, 2017, 28 (02) : 368 - 376
[39] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Parakh, Sagun
Park, John J.
Mendis, Shehara
Rai, Rajat
Xu, Wen
Lo, Serigne
Drummond, Martin
Rowe, Catherine
Wong, Annie
McArthur, Grant
Haydon, Andrew
Andrews, Miles C.
Cebon, Jonathan
Guminski, Alex
Kefford, Richard F.
Long, Georgina V.
Menzies, Alexander M.
Klein, Oliver
Carlino, Matteo S.
BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1558 - 1563
[40] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Park, J. J.
Parakh, S.
Mendis, S.
Rai, R.
Lo, S.
Haydon, A.
Andrews, M. C.
Cebon, J.
Guminski, A.
Kefford, R.
Long, G. V.
Menzies, A. M.
Klein, O.
Carlino, M. S.
ANNALS OF ONCOLOGY, 2016, 27

← 1 2 3 4 5 →